Immunic, inc. announces formation of scientific-medical advisory board

New york, nov. 17, 2020 /prnewswire/ -- immunic, inc. (nasdaq: imux), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced the formation of a...

IMUX Ratings Summary

IMUX Quant Ranking